Evidence map›Paper›PMID 36911469›Full record

ArticleAnnals of Indian Academy of Neurology

Development of Bedside Aphasia Battery in Tamil (BAB-T).

Divya Sivagnanapandian, Shanmuga Preethi, Jasmine Lydia Selvaraj

Abstract read
In one paragraph

Article in Annals of Indian Academy of Neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Divya SivagnanapandianSri Ramachandra Faculty of Audiology and Speech Language Pathology, Sri Ramachandra Institute of Higher Education and Research (SRIHER), Porur, Tamil Nadu, India.
Shanmuga PreethiAudiologist and Speech Language Pathologist, Hearing Aid Centre (HAC), Nungambakkam, Chennai, Tamil Nadu, India.
Jasmine Lydia SelvarajSri Ramachandra Faculty of Audiology and Speech Language Pathology, Sri Ramachandra Institute of Higher Education and Research (SRIHER), Porur, Tamil Nadu, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bedside Aphasia Battery in Tamil (BAB-T) was developed for assessing the linguistic abilities of Tamil-speaking individuals following an acquired brain injury. Method: The conception of the test took place in two phases: Phase 1 was the development of the Bedside Aphasia Battery in Tamil (BAB-T) and phase 2 administration of the test battery in neurotypical adults and patients with aphasia. A Delphi panel was constructed based on selected experts from the field of neuro-communication disorders and linguistics majors in the Tamil language. Recruited participants were surveyed using a modified Delphi method to establish opinions. A three-round Delphi process-derived consensus among the experts regarding the components and subdomains employed in the construction of BAB in Tamil. A pilot study was also conducted on nine participants (six neurotypical and three patients with stroke) to content validate the constructed BAB in Tamil. Outcomes and Results: BAB-T and its subdomains were identified to have excellent internal consistency, test retest and interrater reliability. BAB-T takes approximately 15-20 min to administer and can be employed in busy wards. This tool is especially useful in low-resource countries like India, where professional specialized speech and language services are scarce. The BAB-T significantly differentiates performance between neurotypical adults and patients with aphasia. Additionally, differences among the patient group also reflect the type of fluent and non-fluent aphasia.

Indexed as

AphasiaAssessmentBedside Aphasia Battery in TamilReliabilityScreeningValidity

Identifiers

PMID36911469
PMCPMC9996475

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.